Opinion
Video
Ronald D. Alvarez, MD, MBA, provides closing commentary on the current ovarian cancer treatment landscape and the promising outlook over the next 20 years.
Study Highlights Key RA-ILD Risk Factors, Urges Early Screening
Breaking the Cycle: The Importance of Early Intervention in Hidradenitis Suppurativa
Why Right Heart Catheterization Confirming PAH Diagnosis May Be Underperformed
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
Influenza Antiviral Treatment Underutilized Among Eligible Children, Adolescents
New PsA Data Highlight Long-Term Benefits of Bimekizumab